|
Pink
Ribbons and Disinformation
the
truth about breast cancer and mammography.
steven
ransom
“Women who are
concerned about breast
cancer need facts,
not myths, to make their
own
decisions.” - Irwin
D Bross
In
both the US and the UK, October has also become known as BCAM – breast
cancer awareness month - the month that sees thousands of women
sporting their pink ribbons, all proceeds supposedly going towards
finding a cure. A report from the American College of Preventative
Medicine estimates that 185,000 women a year in the United States are
diagnosed with breast cancer[1]
and the latest Royal Marsden Hospital web-page on breast
cancer reports that 28,000 women in the UK will have been diagnosed
with this disease in 2002.
This article reveals the paucity of
genuine information given to women on the subject of breast cancer and
affords a revealing insight into the vested interests behind the
scenes of the breast cancer industry. And of course, following
the Credence tradition, this article also delivers some very good news
on the subject.
Interpreting those statistics
Whilst
it may be correct that 185,000 women in the United State and 28,000
women per annum in the UK are diagnosed as having breast cancer, how
many of those breast cancer diagnoses are actually correct? And more
importantly, how dangerous are many breast cancers anyway? Before
drawing too sharp a breath at this point, please consider the
following statements. A recent report in the UK Sunday Times on
breast cancer stated: “Whilst mammography detects some potentially
deadly cancers, it also picks up many times more cancers that might
never become symptomatic during the patients’ lifetime, or that could
be treated just as easily if detection were left until the woman could
feel the lump herself. Thus, for every woman saved by early diagnosis,
many others receive painful and potentially dangerous treatments to
destroy tumours that pose little or no threat – tumours that they
might die with, not of.”
[2]
And
further, in a paper entitled 'Dangers and Unreliability of
Mammography; Breast Examination is a Safe, Effective and Practical
Alternative', these well-qualified authors state that the widespread
and virtually unchallenged acceptance of screening has resulted in a
dramatic increase in the diagnosis of ductal carcinoma-in-situ (DCIS),
a pre-invasive cancer, with a current, estimated incidence of about
40,000 US citizens annually. However, say the authors, some 80 percent
of all DCIS cancers never become invasive, even if left untreated.[3]
Today, DCIS is
generally treated by lumpectomy plus radiation or even mastectomy and
chemotherapy. Were you given this information when you were treated
for your DCIS?
Panic makes for easy victims
Irwin D Bross was formerly Director of
Bio-Statistics at Roswell Park Memorial Institute in Buffalo NY,
(Roswell Park Memorial Cancer Hospital). He wrote his thesis on breast
cancer after spending some time researching the nature and outcome of
the disease and discovering that more than half of those diagnosed
with breast cancer had benign lesions that were unable to spread. He
states:
“What most women have is a tumour
which, under a light microscope, looks like a cancer to a pathologist.
Chances are, this tumour lacks the ability to metastasise - to spread
throughout the body - which is the hallmark of a genuine cancer…
Our
discovery was highly unpopular with the medical profession. Doctors
could never afford to admit the scientific truth because the standard
treatment in those days was radical mastectomy. Admitting the truth
could lead to malpractice suits by women who had lost a breast because
of an incorrect medical diagnosis. There is no reason for women to
panic when they hear ‘cancer’. Panic makes them easy victims. Women
who are concerned about breast cancer need facts, not myths, to make
their own decisions.”
[4]
The detection of a breast ‘abnormality’
will of course be of concern, whenever it is discovered. But awareness
of qualified information as to why breast lumps aren’t necessarily
dangerous, and do not automatically require immediate remedial action
(despite the pressure placed upon women to do otherwise), will
hopefully lessen the high level of alarm surrounding this issue. And
then of course, there are the growing number of false-positive
diagnoses.
False positive diagnoses: if more
women knew!
A report on false-positive breast
cancer diagnosis was printed in The Journal of the National Cancer
Institute. Included was the following:
“If
more women knew how common false-positive results are, there might be
less stress and anxiety while waiting to undergo further diagnostic
tests, which sometimes take many weeks. Most importantly, greater
educational initiatives focusing on the role of diet and lifestyle in
breast cancer prevention would empower women to protect themselves
rather than relying solely on early detection of the disease.”
[5]
Radiation risks
Moving on to the mammogram itself, at
patient level, very little information is offered concerning the
dangers associated with mammography. What about the radiation risks
associated with this practice? This condensed report on mammography is
brought to us by Dr Joseph Mercola:
“Screening mammography poses
significant and cumulative risks of breast cancer for pre-menopausal
women. The routine practice of taking four films of each breast
annually results in approximately 1 rad (radiation absorbed dose)
exposure, about 1,000 times greater than that from a chest x-ray.
The premenopausal breast is highly
sensitive to radiation, each 1 rad exposure increasing breast
cancer risk by about 1 percent, with a cumulative 10 percent increased
risk for each breast over a decade’s screening. These risks are even
greater for younger women subject to ‘baseline screening’.
Screening all pre-menopausal women
would cost $2.5 billion annually, about 14% of estimated Medicare
spending on prescription drugs.”
Dr
Mercola states that monthly breast self-examination (BSE), following
brief training, coupled with annual clinical breast examination (CBE)
by a trained healthcare professional, is at least as effective as
mammography in detecting early tumours, and also safe. Dr Mercola also
calls for national networks of BSE and CBE clinics to be established,
staffed by trained nurses, to replace screening mammography. Apart
from their minimal costs, such clinics would also empower women and
free them from increasing dependence on industrialised medicine and
its complicit medical institutions.[6]
It might also help to free women from the constant disinformation,
posing as ‘breast cancer statistics’. Readers may be interested to
know that a simple and safe program of breast self-examination is
included in the appendices at the back of
Great News on
Cancer in the 21st Century.
Mammography is a fraud
Dr John McDougall has made a thorough
review of pertinent literature on mammograms. He points out that the
$5-13 billion per year generated by mammograms controls the
information that women get. Fear and incomplete data are the tools
commonly used to persuade women to get routine mammograms. Says Dr
McDougall:
“I went into medicine with the idea
that I was going to save all of these lives with all the tricks and
tools that medical doctors learned. And what I found was that very few
of my patients got well. I often did harm to them. This was quite
disturbing to me as a young doctor. What was even more disturbing was
to find out that this failure had been fairly well documented in the
scientific literature - but it doesn’t fit anybody’s advertising
campaign.
Science says one thing and the public believes another because the
public relations machine benefits the economics of the drug and
medical industries. Mammography is a fraud. The 8th January 2000 issue
of The Lancet carried an article stating that mammography is
unjustifiable. Of the eight studies done, six of them showed that
mammography doesn’t work, and yet the American public believes this is
a time-honoured, definite way of saving their lives from breast
cancer.”
[7]
Cancer risks from breast compression
As
early as 1928, physicians were warned to handle cancerous breasts with
care, for fear of accidentally disseminating cells and spreading
cancer.[8]
Even so, mammography entails tight and often painful compression of
the breast, particularly in pre-menopausal women. This may lead to a
spread of malignant cells by rupturing small blood vessels in, or
around small, as yet undetected breast cancers.[9]
Mammograms do not prevent breast cancer. Dr Tim O’Shea warns that
harmless breast cancers can be made active by the compressive force of
routine mammography.[10]
Mammography offers no benefit above
self-examination
Extensive studies of breast cancer histories show no increased
survival rate from routine screening mammograms. After reviewing all
available literature in the world on the subject, noted researchers
Drs Wright and Mueller, of the University of British Columbia,
recommended the withdrawal of public funding for
mammography screening, because, “the benefit achieved is marginal
and the harm caused is substantial.”
[11]
The
harm to which they are referring includes the constant worrying and
emotional distress, as well as the tendency for unnecessary procedures
and testing to be done based on results which can have a
false-positive rate as high as 50%.[12]
A
seven year study of 90,000 women by Professor Anthony Miller of
Toronto University has shown that mammography had no impact on women
aged between 40 – 49, and for women over 50, it has shown no benefit
over and above what is detected by annual examinations by specialists
and self-examination.[13]
In his book The Politics of Cancer,
internationally recognised carcinogens expert, Dr Samuel Epstein,
warns us:
“…
the US National Cancer Institute is now agreed that large-scale
mammography screening programs are likely to cause more cancers than
could possibly be detected.”
[14]
In Radiation and Human Health, Dr John
Goffman writes:
“There will be more breast cancers induced by the procedure than there
will be women saved from breast cancer death by early discovery of
lesions.”
[15]
But as Dr John McDougall has already
stated, “… by the time a tumour is large enough to be detected by
mammography, it has been there as long as 12 years! It is therefore
ridiculous to advertise mammography as ‘early detection’.”
Mammography and vested interests
The
American Cancer Society, the world’s most wealthy, non-profit
institution (it has even made political contributions[16]),
has close connections to the mammography industry. Five radiologists
have served as ACS presidents. The ACS promotes the interests of the
major manufacturers of mammogram machines and films, including Siemens,
DuPont, General Electric, Eastman Kodak, and Piker. The
mammography industry also conducts research for the ACS and its
grantees, serves on advisory boards, and donates considerable funds.[17]
Pharmaceutical giant DuPont is a substantial backer of the ACS Breast
Health Awareness Program. ACS sponsors television shows and other
media productions promoting mammography; produces advertising,
promotional, and information literature for hospitals, clinics,
medical organisations, and doctors; produces educational films, and,
of course, lobbies Congress for legislation promoting availability of
mammography services. In virtually all its important actions, the ACS
has been, and remains strongly linked with the mammography industry,
while ignoring or attacking the development of viable alternatives.[18]
ACS promotion continues to attract women
of all ages into mammography centres, leading them to believe that
mammography is their best hope against breast cancer. According to the
report, a leading Massachusetts newspaper featured a photograph of two
women in their twenties in an ACS advertisement that promised early
detection results “nearly 100 percent of the time.” An ACS
communications director was questioned by journalist Kate Dempsey and
admitted the following, in an article published by the Massachusetts
Women’s Community journal Cancer:
“The ad isn’t based on a study. When you make an advertisement, you
just say what you can to get women in the door. You exaggerate a
point… Mammography today is a lucrative and highly competitive
business.”
[19]
Those ‘exciting’ breast cancer drugs!
The following BBC News item on breast
cancer makes reference to the drug Tamoxifen:
Breast cancer deaths plummet: Early detection has saved
lives. An unprecedented fall in the number of women dying from breast
cancer has been hailed by scientists. A drug, Tamoxifen, developed in
the UK, appears mainly responsible for almost a 30% drop in deaths in
the UK over the last decade, reported the Lancet medical journal. It
is the most sudden drop in mortality for a common cancer seen anywhere
in the world.
[20]
The above news item represents nothing
more than the standard ‘advertorial’ we have come to expect from
today’s toothless media. Everything of importance has been left out.
Tamoxifen (other names include Nolvadex, Tamofen and Noltam) is an
anti-estrogen drug manufactured by Astra Zeneca Pharmaceuticals and is
currently prescribed for between 2 and 5 years in duration, as a
single daily dose of around 20 mg.
Tamoxifen – a human carcinogen
Nowhere is it mentioned in any of the Tamoxifen promos that the World
Health Organisation formally designated Tamoxifen as a human
carcinogen back in 1996, grouping this treatment with around 70 other
chemicals — about one quarter of them pharmaceuticals.[21]
Quite shockingly, in response to WHO’s announcement, the National
Cancer Institute and Zeneca Pharmaceuticals lobbied California
regulators to keep them from adding Tamoxifen to their list of
carcinogens. As Duncan Roades, editor of Nexus Magazine
stated:
“Here is open evidence of a government agency, chartered to find a
cure for cancer, flagrantly colluding with a drug company to keep a
known carcinogen on the market and keep the public from learning of
its dangers.… This should have been a controversy of high order;
instead it was barely reported in the press and few heard about it.”
[22]
The
long-term safety of Tamoxifen use in healthy women has never been
established. In particular, Tamoxifen can cause uterine cancer.
Cancers of the liver, ovaries and gastrointestinal tract have also
been reported. A study at Johns Hopkins University by Yager and Shi
found that Tamoxifen is a promoter of liver cancer. When WHO announced
Tamoxifen as a known carcinogen in 1996, the NCI study on this drug
was abruptly curtailed, but not before 33 women taking Tamoxifen at
that time developed endometrial cancer.[23]
Readers are strongly advised to research
the side-effects of all chemotherapy/hormonal drugs prescribed to them
for their particular condition. Further important information on
Tamoxifen and other breast cancer drugs is available from Great
News on Cancer in the 21st Century.
‘Male-oriented’ Breast
Cancer Awareness Month
Breast Cancer Awareness Month in the US
(and the pink ribbon campaigns here in the UK) is designed to raise
public awareness of breast cancer. BCAM is held in October and is
sponsored primarily by Zeneca (the makers of Tamoxifen and a former
subsidiary of Industry giant ICI), along with the American Academy of
Family Physicians and Cancer Care Inc. In the US, National Breast
Cancer Awareness Month is now governed by a board consisting of 17
organisations, including the American Cancer Society, the Centers for
Disease Control and the National Cancer Institute. Behind the scenes
and Breast Cancer Awareness Month is nothing more than a business
jamboree, with a little bit of sincerity thrown in on the side.
Male and money-oriented
The following extract is taken from the
British Medical Journal 'Selling Sickness' debate:
“In some countries, women are invited
for mammography in a letter in which the date and time of the
appointment have already been fixed. This puts pressure on these
women, who must actively decline the invitation if they don’t want to
be screened. Sometimes, women are asked to give reasons for not
attending appointments, as if it were a civic duty. In leaflets, women
get simple messages - that cancer detected early can be cured, and
early cancers can often be treated with breast-conserving surgery.
The
data tell another story: no reliable evidence shows that breast
screening saves lives; breast screening leads to more surgery,
including more mastectomies; and estimates show that more than a tenth
of healthy women who attend a breast screening program experience
considerable psychological distress for many months.”
[24]
An unnecessary climate of fear
In an
article focusing on predictive (genetic) testing for breast cancer, a
Dr Miryam Wahrman notes that: “… women must grapple with whether to
undergo major surgery, or to watch and wait.”
[25]
This is diabolical position. The authority figure in the breast cancer
equation - the oncologist - has now been given permission to pronounce
a psychological, pharmaceutical and surgical curse upon healthy and
unsuspecting patients. “You might get it. Who knows?” That so
unsound a knowledge-base is gaining such stature in society today is
nothing short of criminal. Women are being treated as mere guinea
pigs, being herded from pillar to post and trustingly receiving
diagnoses and treatments that are causing serious psychological and
physical harm, and tragically, more often than not, leading to the
death of the 'patient'.
In surveying the conventional breast
cancer scene, in fact, in surveying the conventional cancer scene in
general, one can only conclude that 'death by doctoring' is alive and
well in the 21st century. No apologies are offered for the grim
picture that has emerged in this article with regard to conventional
breast cancer treatment and ‘care’. On the brink of the American Civil
War, it was Patrick Henry who poignantly stated:
“We are apt to shut our eyes against a
painful truth, and listen to the song of the siren till she transforms
us into beasts. For my part, whatever anguish of spirit it may cost, I
am willing to know the whole truth, to know the worst, and provide for
it.”
Empowering women
Were
there only one side to this cancer story, then it would be a
depressing read indeed. In Great News on Cancer in the 21st
Century, there are numerous testimonies as to the positive effects
of treating cancer without the use of conventional drugs.
Hazel had been given a virtual
death sentence by her cancer doctor, telling her that although there
was an 86% recovery from her type of breast cancer, she was
unfortunately in the smaller category. As previously noted, Hazel’s
chemotherapy was only making her feel terrible, and she decided that
if she was going to die, then she would do so without further
conventional treatment. Hazel began a regime of intravenously
administered Vitamin C and supplements including Vitamin B17 and paid
great attention to her diet.
She soon began to feel a great deal
better. She regained her weight and her hair and her appetite. About
nine months following the diagnosis, she was troubled with lower back
pain and visited her doctor. He suggested a further scan based on
Hazel’s lower back pain, which the doctor believed was possibly the
result of her cancer having spread to the base of her spine. Hazel
said there was no way she was going for more chemotherapy or scans
which she believes in themselves can trigger carcinogenic activity.
Instead, Hazel supplemented her Vitamin C
regime with a course of Vitamin B17 kernels, as well as maintaining a
sensible diet and staying away from her conventional cancer physician.
The blood count taken by her GP before Christmas read as normal. She
feels very healthy and feels passionately that people need to know
that there are alternative cancer treatments available and speaks to
groups on this subject.
There is some very good news indeed on
cancer. And fortunately, it doesn’t depend on the mighty orthodoxy to
deliver it! With regard to breast cancer in general, for those women
facing this disease or who are worried about the prospect, the
following advice is offered by natural health advocate Dr Joseph
Mercola:
“Breast Cancer Awareness Month is indeed a powerful time to educate,
awaken and empower women to the real causes, preventative measures and
truly effective cures for breast cancer. But, let’s not be duped or
compromised in the process.”
[26]
Avoid
being duped. Obtain a copy of
Great News
on Cancer in the 21st Century and begin that vital journey of
discovery!
Steven
Ransom
References
|